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Abstract
Anxiety, a sustained state of heightened apprehension in the absence of immediate threat, becomes
severely debilitating in disease states1. Anxiety disorders represent the most common of
psychiatric diseases (28% lifetime prevalence)2, and contribute to the etiology of major depression
and substance abuse3,4. Although it has been proposed that the amygdala, a brain region important
for emotional processing5–8, has a role in anxiety9–13, neural mechanisms that control anxiety
remain unclear. Here we explore neural circuits underlying anxiety-related behaviors by using
optogenetics with two-photon microscopy, anxiety assays in freely moving mice, and
electrophysiology. With the capability of optogenetics14–16 to control not only cell types but also
specific connections between cells, we observed that temporally precise optogenetic stimulation of
basolateral amygdala (BLA) terminals in the central nucleus of the amygdala (CeA-achieved by
viral transduction of the BLA with a codon-optimized channelrhodopsin followed by restricted
illumination in downstream CeA - exerted an acute, reversible anxiolytic effect. Conversely,
selective optogenetic inhibition of the same projection with a third-generation halorhodopsin15
(eNpHR3.0) increased anxiety-related behaviors. Importantly, these effects were not observed
with direct optogenetic control of BLA somata, possibly owing to recruitment of antagonistic
downstream structures. Together, these results implicate specific BLA-CeA projections as critical
circuit elements for acute anxiety control in the mammalian brain, and demonstrate the importance
of optogenetically targeting defined projections, beyond simply targeting cell types, in the study of
circuit function relevant to neuropsychiatric disease.
Despite the high prevalence1,2 of anxiety disorders, the underlying neural circuitry is
incompletely understood. Available treatments are inconsistently effective or, in the case of
benzodiazepines, addictive and linked to significant side-effects including cognitive
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impairment and respiratory suppression17, pointing to the need for deeper understanding of
anxiety control mechanisms in the mammalian brain.
Although amygdala microcircuitry for conditioned fear has been optogenetically
dissected18,19, the causal underpinnings of unconditioned anxiety11 have not yet been
investigated with cellular precision. Pointing to the need for precise optogenetic exploration,
the amygdala is composed of functionally and morphologically heterogeneous subnuclei
with complex interconnectivity. The BLA is primarily glutamatergic (~90%)20, 21 while the
CeA, which encompasses the centrolateral (CeL) and centromedial (CeM) nuclei, consists of
~95% GABAergic medium spiny neurons22. The primary output region of the amygdala is
the CeM23,24 which (when chemically or electrically excited) mediates autonomic and
behavioral responses associated with fear and anxiety via projections to the brainstem25.
Because patients with generalized anxiety disorder may have abnormal activity arising from
the BLA and CeM11, and since BLA neurons excite GABAergic CeL neurons26 that provide
feed-forward inhibition onto CeM “output” neurons6,18,19, we considered that the BLA-
CeL-CeM circuit could be causally involved in anxiety. However, BLA pyramidal neurons
as a whole could have varied and antagonistic roles in diverse projections throughout the
brain, with targets including the bed nucleus of the stria terminalis (BNST), nucleus
accumbens, hippocampus and cortex26.
We therefore developed a method to selectively control BLA terminals in the CeA
(Supplementary Methods). BLA glutamatergic projection neurons were transduced with an
adeno-associated virus serotype 5 (AAV5) carrying codon-optimized channelrhodopsin
(ChR2)-eYFP under control of the CaMKIIαeYFP promoter followed by unilateral
implantation of a bevelled guide cannula to allow preferential illumination of the non-
transduced CeL (Supplementary Figs. 1,2). In vivo electrophysiological recordings were
used to determine illumination parameters for selective control of those BLA terminals in
the CeA without nonspecific control of all BLA somata (Supplementary Fig. 3).
To investigate the functional role of the BLA-CeA pathway in anxiety, we probed freely
moving mice under projection-specific optogenetic control in two well-validated27 anxiety
assays: the elevated-plus maze (EPM) and the open-field test (OFT; Fig. 1a–e). Mice display
anxiety-related behaviors in open spaces; therefore increased time spent in EPM open arms
or in the OFT center is interpreted as reduced anxiety27. To test whether anxiety-related
behaviors could be related to activation of the BLA-CeA projection, and not all BLA somata
as a whole, we compared mice receiving projection-specific photostimulation (ChR2:BLA-
CeA; Fig. 1a) to a group with identical illumination parameters transduced with a control
virus (eYFP:BLA-CeA), and to another control group expressing ChR2 in the BLA
receiving direct illumination of the BLA (ChR2:BLA (somata)). Photostimulation of BLA
terminals in the CeA (ChR2:BLA-CeA) increased open-arm time (F1,42=69.09, p<0.00001;
Fig. 1b,c) and probability of open-arm entry from the maze center (F1,42=24.69, p<0.00001:
Fig. 1c inset; Supplementary Movie) on the EPM, as well as increased center time in the
OFT (F1,105=24.46, p<0.00001; Fig. 1d,e), reflecting anxiety reduction, without impaired
locomotion (Supplementary Fig. 4). In contrast, the ChR2:BLA(somata)group showed
reduced open arm time (F1,42=6.20, p=0.02; Fig. 1b,c) and probability of open arm entry
(F1,42=5.15, p=0.03) during photostimulation relative to eYFP:BLA-CeA controls, reflecting
a distinct anxiogenic effect. Thus, selective illumination of BLA projections to the CeA, but
not of BLA somata nonspecifically, produced an acute, rapidly-reversible anxiolytic effect.
Next we investigated the physiological basis of this light-induced anxiolysis. We considered
that preferential photostimulation of BLA terminals in the CeL could activate CeL neurons
and exert feed-forward inhibition onto brainstem-projecting CeM output neurons18,19 to
implement anxiolysis. To test this, we undertook in vivo experiments, with light delivery
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protocols matched to those delivered in the behavioral experiments, using activity-dependent
immediate early gene (c-fos) expression to track neuronal activation. We quantified the
proportion of neurons in the BLA, CeL and CeM (Supplementary Fig. 5) within each group
that expressed eYFP or showed c-fos immunoreactivity. Opsin expression was specific to
BLA glutamatergic neurons, and was not observed in intercalated cells (Supplementary Fig.
6). No group differences were detected in the proportion of eYFP-positive cells within each
region (Supplementary Fig. 5). We found a significantly higher proportion of c-fos-positive
BLA cells in the ChR2:BLA(somata) group (F2,9=10.12, p<0.01), relative to ChR2:BLA-
CeA or eYFP:BLA-CeA groups (p<0.01 and p<0.05, respectively), but no detectable
difference between the ChR2:BLA-CeA and eYFP:BLA-CeA groups, indicating that the
bevelled cannula shielding effectively prevented BLA somata photostimulation. A higher
proportion of CeL neurons expressed c-fos in the ChR2:BLA-CeA group relative to the
eYFP:BLA-CeA group (F2,9=4.54, p=0.04), but not the ChR2:BLA(somata)group
(Supplementary Fig. 5). Thus, the in vivo illumination of BLA-CeA projections that
triggered acute anxiolysis was found to excite CeL neurons without activating all BLA
somata nonspecifically.
To test the hypothesis that preferential illumination of BLA-CeL terminals induced feed-
forward inhibition of CeM output neurons, we combined whole-cell patch-clamp
electrophysiology with two-photon imaging to visualize the microcircuit while
simultaneously probing the functional relationships among these cells during projection-
specific optogenetic control (Fig. 2a–f). BLA neurons showed high-fidelity spiking to direct
illumination (Fig. 2b). Illumination of BLA terminals in CeL elicited excitatory responses in
both weakly- and strongly-connected CeL cells (n=16; Fig. 2c).
To test whether illumination of BLA-CeL synapses could block CeM spiking via feed-
forward inhibition from CeL neurons, we recorded from CeM neurons while selectively
illuminating BLA-CeL synapses (Fig. 2d). Indeed, we observed potent spiking inhibition in
CeM cells upon illumination of BLA-CeL terminals (Fig. 2d; F2,11=15.35, p=0.004). Figure
2e shows CeM responses recorded during illumination of ChR2-expressing BLA neurons in
the CeM; importantly, the very same CeM neurons (n=7) showed net excitation upon broad
illumination of BLA inputs to the CeM (Fig. 2e), but showed net inhibition upon selective
illumination of BLA inputs to the CeL (Fig. 2f). These data from a structurally- and
functionally-identified microcircuit25 illustrate that the balance of direct and indirect inputs
from the BLA to the CeM can modulate CeM activity. We then examined whether
overlapping or distinct populations of BLA neurons projected to the CeL and CeM in the
mouse (Supplementary Fig. 7) by two-photon imaging in 350 μm-thick coronal slices. Of
the BLA neurons sampled (n=18, Supplementary Fig. 7); 44% projected to the CeL alone
and 17% projected to the CeM alone, with only one cell observed to project to both the CeL
and the CeM.
Since in vivo c-fos assays had indicated that illumination of BLA terminals in the CeL
sufficed to drive excitation of postsynaptic CeL neurons but not to recruit efficiently BLA
neurons as a whole, we next investigated the properties of optogenetically-driven terminal
stimulation in this microcircuit using whole-cell recordings. We first recorded from BLA
pyramidal neurons expressing ChR2 and moved a restricted light spot (~125 μm-diameter)
in 100 μm steps from the cell soma, both in a direction over the visually-identified axon and
in a direction where there was no axon collateral, illustrating the spatial properties of light
scattering in this circuit (Fig. 3a,b); spiking fidelity in the BLA neuron and evoked inward
currents are summarized (Fig. 3a). Next, we found that typical photostimulation parameters
drove reliable transmission when delivered to BLA-CeA synapses (assayed with recordings
from postsynaptic CeL neurons; Fig. 3b; Supplementary Fig. 8); in contrast, when recording
from the BLA somata instead ~300 μm from the light spot, we did not observe reliable
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antidromically-driven action potential firing (only ~5% reliability) despite use of the very
same BLA-CeA synapse illumination conditions that elicited 100% reliable transmitter
release from the illuminated terminals and the same cells known to spike robustly in
response to somatic illumination (Fig. 3b). These results were consistent with the c-fos
immunoreactivity and behavioral data (Fig. 1) and held even upon bath application of
GABA and glutamate receptor antagonists (n=7) to eliminate local circuitry effects. The
marked difference between effective synaptic transmission and antidromic spiking fidelity
(p=0.0039; Fig. 3b, inset) reveals that optogenetically-driven vesicle release may occur in
the absence of reliable antidromic drive, a potentially useful property that may relate to
projection parameters such as axon caliber and myelination status (optogenetic stimuli will
recruit thinner axons more efficiently than electrical stimuli), as well as experimental light
intensity and spatial restriction properties.
To further confirm that the anxiolytic effect was due to the selective activation of BLA-CeL
projections alone, and not BLA axons passing through the CeA, nor back-propagation of
action potentials to BLA cell bodies that would then innervate all BLA projection target
regions, we tested whether local glutamate receptor antagonism would attenuate light-
induced anxiolytic effects. This distinction is critical, since previous reports that CeA lesions
that alter anxiety are confounded by the ablation of BLA projections to the BNST passing
through CeA28. In a separate group of mice, we selectively illuminated BLA-CeA terminals
as before (n=8; Supplementary Fig. 1), but infused glutamate antagonists or saline via the
fiberoptic guide cannula, before testing on the EPM and OFT. Confirming a local synaptic
mechanism rather than control of fibers of passage, intra-CeA glutamate receptor
antagonism abolished light-induced reductions in anxiety as measured by open-arm time
(F1,35=8.61; p=0.008) and probability of open-arm entry on the EPM (F1,35=5.92, p=0.02),
and center time during the OFT (F1,77=13.99; p=0.0006; Fig. 3c,d). Importantly, drug
treatment did not impair locomotor activity (Supplementary Fig. 9), and in acute slices time-
locked light-evoked excitatory responses were abolished upon bath application of 2,3-
dihydroxy-6-nitro-7-sulfamoyl-benzo[f] quinoxaline-2,3-dione (NBQX) and (2R)-amino-5-
phosphonopentanoate (AP5) (Supplementary Fig. 10). These data demonstrate that the light-
induced anxiolytic effects were caused by the activation of BLA-CeA synapses, and not
attributable to BLA projections to distal targets passing through the CeA.
Finally, to test whether basal anxiety-reducing processes could be blocked by selectively
inhibiting the BLA-CeA pathway, we bilaterally transduced either eNpHR3.0 -which
hyperpolarizes neuronal membranes upon illumination with amber light15 - or eYFP alone,
under the CaMKIIα promoter in the BLA, and implanted bilateral bevelled guide cannulae
to allow selective illumination of BLA terminals in the CeA (Supplementary Fig. 11).
eNpHR3.0 expression was restricted to glutamatergic neurons in the BLA, and the
eNpHR3.0:BLA-CeA group showed elevated levels of c-fos expression, relative to the
eYFP:BLA-CeA and eNpHR3.0:BLA(somata) groups, in the CeM (p<0.05; Supplementary
Fig. 12), consistent with the hypothesis that inhibition of BLA-CeL synapses suppresses
feed-forward inhibition from CeL neurons to CeM neurons, thereby increasing CeM
excitability and the downstream processes leading to increased anxiety phenotypes.
Selective illumination of eNpHR3.0-expressing axon terminals reduced the probability of
both spontaneously occurring (frequency: F1,8=32.99, p=0.00024; amplitude: F1,8=21.96,
p=0.001; Supplementary Fig. 13) and electrically-evoked (F1,10=10.79, p=0.006; Fig. 4a)
vesicle release, without preventing spiking at the soma (Supplementary Fig. 14). BLA
somata inhibition did not induce an anxiogenic response, perhaps owing to the simultaneous
decrease in direct BLA-CeM excitatory input. We also found that the eNpHR3.0:BLA-CeA
group showed reduced open-arm time and probability of open-arm entry on EPM
(F1,40=21.08, p<0.00001; and F1,40=19.93, p<0.00001, respectively; Fig. 4b,c) and center-
time in the OFT (F1,100=18.919, p<0.00001; Fig. 4d,e) during photostimulation when
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compared to the eYFP and BLA(somata) groups, without altering locomotor activity
(Supplementary Fig. 15). These data demonstrate that preferential inhibition of BLA-CeL
synapses acutely increases anxiety-like behaviors.
Here, we have identified the BLA-CeL pathway as a neural substrate for real-time
bidirectional modulation of the unconditioned expression of anxiety. The observation that
selective illumination of specific BLA terminals produces distinct, and even opposite,
behavioral responses from illumination of all glutamatergic BLA somata nonspecifically,
points to the essential value of optogenetic control in causally dissecting intact neural
circuitry, and suggests that multiple subpopulations or projections of BLA neurons can act
in opposition (e.g. direct excitation of CeM along with feed-forward inhibition of CeM).
Neural circuitry arranged in this way provides many opportunities for modulation of
expression of anxiety phenotypes; for example, this microcircuit is well-positioned to be
influenced by top-down cortical control from regions important for processing fear and
anxiety, including the prelimbic, infralimbic and insular cortices that provide robust
innervation to the BLA and CeL.
These data are consistent with reports implicating CeA involvement in anxiety9,11,12, but it
is important to note that our findings do not exclude downstream or parallel circuits
including the BNST28, the insular and prefrontal cortices29, and the septal-hippocampal
circuit30; for example, stress induces CeL release of corticotropin releasing hormone (CRH)
in the BNST28. In the course of providing insight into native anxiogenic and anxiolytic
processes, these findings demonstrate that anxiety is continuously regulated by balanced
antagonistic pathways within the amygdala, and illustrate the importance of resolving
specific projections in the study of neural circuit function relevant to psychiatric disease.
Methods Summary
Virus-mediated opsin gene expression
The pAAV-CaMKIIα-hChR2(H134R)-eYFP, pAAV-CaMKIIα-eYFP and pAAV-
CaMKIIα-eNpHR3.0-eYFP plasmids were designed and constructed by standard methods
and packaged as AAV5. 0.5 μl of virus was injected into the BLA. Maps and clones are
available at www.optogenetics.org.
In vivo projection-specific targeting
To investigate the role of the BLA-CeL pathway in modulating anxiety, we performed viral
transduction and surgical implantation of bevelled guide cannulae to allow selective
illumination of BLA fibers in the CeA under stereotaxic guidance. Behavioral,
electrophysiological and imaging data were collected 4–6 weeks following surgery.
Two-photon imaging and functional mapping using ex vivo electrophysiology
Acute slices were collected for two-photon imaging and ex vivo electrophysiological
recordings. While light-stimulation parameters used in vivo were delivered via fiberoptic
and light in ex vivo experiments was delivered onto coronal sections, we matched light
power density at our target region ~6mW/mm2. Whole-cell recordings were made from
BLA pyramidal neurons simultaneously during two-photon visualization of neuronal
processes with Alexa Fluor dye. We visually tracked axonal projections from BLA neurons
to the CeL nucleus. We recorded from CeL neurons upon illumination with an aperture-
restricted light spot (~125 μm diameter), mimicking the preferential illumination of BLA
terminals, but not BLA somata, delivered in vivo. Two-photon imaging allowed axonal
tracking to the CeM, where whole-cell recordings were collected from CeM neurons in the
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terminal field of CeL axons, with aperture-restricted illumination over the CeL to allow
selective illumination of BLA terminals in the CeL whilst recording from the CeM neuron.
Opsin expression validation and immunohistochemistry
To validate specificity, sensitivity and spatial distribution of opsin expression as well as
neuronal activity, brain slices were prepared for optical microscopy and
immunohistochemistry. Coronal sections were stained for DAPI and immunoreactivity for c-
fos. Quantitative analyses of confocal images were performed with both staining and
analysis blind to experimental condition.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Projection-specific excitation of BLA terminals in the CeA induces acute reversible
anxiolysis
a) Mice were housed in a high-stress environment before behavioral manipulations and
receive 5-ms light pulses at 20Hz for all light-on conditions. (b–c) ChR2:BLA-CeA mice
(n=8) received selective illumination of BLA terminals in the CeA during the light-on epoch
on the EPM; see ChR2:BLA-CeA representative path (b), which induced an increase in
open-arm time upon photostimulation relative to eYFP:BLA-CeA (n=9) and
ChR2:BLA(somata) (n=7) controls (c), and an increase in probability of open arm entry (see
inset). (d–e) ChR2:BLA-CeA mice also increased center time on the OFT, as seen in a
representative path (d), during light-on epochs relative to light-off epochs and eYFP:BLA-
CeA and ChR2:BLA(somata) controls (e).
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Figure 2. Projection-specific excitation of BLA terminals in the CeA activates CeL neurons and
elicits feed-forward inhibition of CeM neurons
a) Two-photon images of representative BLA, CeL and CeM cells imaged from the same
slice, overlaid on a brightfield image. (b–f) Schematics of the recording and illumination
sites for the associated representative current-clamp traces (Vm=~−70 mV. b)
Representative BLA pyramidal neuron trace expressing ChR2, all of which spiked for every
pulse (n=4). c) Representative trace from a CeL neuron in the terminal field of BLA
projection neurons, showing both sub- and supra-threshold excitatory responses upon
photostimulation (n=16). Inset left, population summary of mean probability of spiking for
each pulse in a 40-pulse train at 20Hz, dotted lines indicate s.e.m. Inset right, frequency
histogram showing individual cell spiking fidelity; y-axis is the number of cells per each 5%
bin. d) Six sweeps from a CeM neuron spiking in response to a current step (~60 pA;
indicated in black) and inhibition of spiking upon 20Hz illumination of BLA terminals in the
CeL. Inset, spike frequency was significantly reduced during light stimulation of CeL
neurons (n=4; spikes/second before (49±9.0), during (1.5±0.87), and after (33±8.4)
illumination; mean±s.e.m.). (e–f) Upon broad illumination of the CeM, voltage-clamp
summaries show that the latency of excitatory postsynaptic currents (EPSCs) is significantly
shorter than the latency of inhibitory postsynaptic currents (IPSCs), whereas there was a
non-significant difference in the amplitude of EPSCs and IPSCs (n=11; *p=0.04, see insets).
The same CeM neurons (n=7) showed either net excitation when receiving illumination of
the CeM (e) or net inhibition upon selective illumination of the CeL (f).
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Figure 3. Light-induced anxiolytic effects are attributable to activation of BLA-CeL synapses
(a–b) Schematic of the recording site and illumination positions, as whole-cell recordings
were performed at each illumination location, in 100 μm increments away from the cell
soma both over a visualized axon and in a direction that was not over an axon (inset).
Normalized summary of spike fidelity and depolarizing current (a) to a 20Hz train delivered
at various distances from the soma. (b) Representative traces upon ~125 μm diameter
illumination at various locations within each slice (n=7). Illumination of BLA somata elicits
high-fidelity spiking (top). Illumination of BLA terminals in CeL elicits strong excitatory
responses shown in voltage-clamp in the postsynaptic CeL neuron (middle), but does not
elicit reliable antidromic spiking in the BLA neuron itself (bottom), summarized in a
frequency histogram (inset). (c,d) A separate group of ChR2:BLA-CeA mice (n=8)
performed the EPM and OFT twice, one session preceded with intra-CeA infusions of saline
(red) and the other session with glutamate receptor antagonists NBQX and AP5 (purple),
counter-balanced for order. Glutamate receptor blockade in the CeA attenuated light-
induced increases in both open arm time (c) and probability of open arm entry (inset) on the
EPM and center time on the OFT (d, inset shows pooled summary), without altering
baseline performance.
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Figure 4. Selective inhibition of BLA terminals in the CeA induces an acute and reversible
increase in anxiety
(a–e) Mice were group-housed in a low-stress environment and received bilateral constant
594 nm light during light-on epochs. a) Selective illumination of eNpHR3.0-expressing
BLA terminals suppresses vesicle release evoked by electrical stimulation in the BLA.
Schematic indicates the locations of the stimulating electrode, the recording electrode and
the ~125 μm diameter light spot. Representative CeL EPSCs before (Off1), during (On) and
after (Off2) selective illumination of eNpHR3.0-expressing BLA terminals. Normalized
EPSC amplitude summary data from sections containing BLA neurons expressing
eNpHR3.0 (n=7) and non-transduced controls (n=5) show that selectively illuminating
BLA-CeL terminals reduces (*p=0.006) electrically-evoked EPSC amplitude in postsynaptic
CeL neurons relative to non-transduced control slice preparations (inset). (b–c)
Representative eNpHR3.0:BLA-CeA path (b) indicates reduced open arm time (c) and
probability of open arm entry (inset) during illumination, relative to controls. (d–e)
Representative eNpHR3.0:BLA-CeA path (d) reflects reduced center time on the OFT (e)
for the eNpHR3.0:BLA-CeA group during light-on, but not light-off, epochs as compared to
controls (inset shows pooled data).
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